Considering the fact that OXY is an active natural compound that exhibits potent inhibition of the PI3K/AKT signal transduction pathway and proliferation induced by TNF-α (as depicted in Figure 9), our discovery sheds light on the possibility to develop OXY as a novel PI3K/AKT-based therapy to improve psoriasis treatment effectiveness. This evidence concerns the gene AKT1 and psoriasis.